Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.

2.50
Hdl Handle:
http://hdl.handle.net/10547/224577
Title:
Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.
Authors:
Guinn, Barbara-Ann; Casey, Garrett; Collins, Sara A.; O'Brien, Tim; Alexander, M. Yvonne; Tangney, Mark
Abstract:
The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland on May 15 and 16, 2008 (http://crr.ucc.ie/isgct/). The meeting was jointly organized with the British Society for Gene Therapy and the International Society for Cell and Gene Therapy of Cancer. Because of the location of the conference and the co-organization of this meeting with the British and International Gene Therapy societies, the meeting enjoyed a range of talks from some of the major leaders in the field. Particularly notable were the talented molecular and cell biologists from Ireland who have contributed cutting edge science to the field of gene therapy. Topics including cardiovascular disease, repair of single-gene disorders, and cancer gene therapy were discussed with presentations ranging from basic research to translation into the clinic. Here we describe some of the most exciting presentations and their potential impact on imminent clinical gene therapy trials.
Affiliation:
Department of Haematological Medicine, King's College London School of Medicine, The Rayne Institute, London SE5 9NU, United Kingdom. barbara.guinn@kcl.ac.uk
Citation:
Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer. 2008, 19 (10):967-78 Hum. Gene Ther.
Publisher:
Mary Ann Liebert
Journal:
Human gene therapy
Issue Date:
Oct-2008
URI:
http://hdl.handle.net/10547/224577
DOI:
10.1089/hum.2008.085
PubMed ID:
18652546
Additional Links:
http://online.liebertpub.com/doi/abs/10.1089/hum.2008.085
Type:
Article
Language:
en
ISSN:
1557-7422
Appears in Collections:
Biomedicine and Nutrition Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorGuinn, Barbara-Annen_GB
dc.contributor.authorCasey, Garretten_GB
dc.contributor.authorCollins, Sara A.en_GB
dc.contributor.authorO'Brien, Timen_GB
dc.contributor.authorAlexander, M. Yvonneen_GB
dc.contributor.authorTangney, Marken_GB
dc.date.accessioned2012-05-18T10:34:34Z-
dc.date.available2012-05-18T10:34:34Z-
dc.date.issued2008-10-
dc.identifier.citationTripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer. 2008, 19 (10):967-78 Hum. Gene Ther.en_GB
dc.identifier.issn1557-7422-
dc.identifier.pmid18652546-
dc.identifier.doi10.1089/hum.2008.085-
dc.identifier.urihttp://hdl.handle.net/10547/224577-
dc.description.abstractThe second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland on May 15 and 16, 2008 (http://crr.ucc.ie/isgct/). The meeting was jointly organized with the British Society for Gene Therapy and the International Society for Cell and Gene Therapy of Cancer. Because of the location of the conference and the co-organization of this meeting with the British and International Gene Therapy societies, the meeting enjoyed a range of talks from some of the major leaders in the field. Particularly notable were the talented molecular and cell biologists from Ireland who have contributed cutting edge science to the field of gene therapy. Topics including cardiovascular disease, repair of single-gene disorders, and cancer gene therapy were discussed with presentations ranging from basic research to translation into the clinic. Here we describe some of the most exciting presentations and their potential impact on imminent clinical gene therapy trials.en_GB
dc.language.isoenen
dc.publisherMary Ann Lieberten_GB
dc.relation.urlhttp://online.liebertpub.com/doi/abs/10.1089/hum.2008.085en_GB
dc.rightsArchived with thanks to Human gene therapyen_GB
dc.subjectmeeting reporten_GB
dc.subjectgene and cell therapyen_GB
dc.subjectcancer gene therapyen_GB
dc.subject.meshCardiovascular Diseases-
dc.subject.meshClinical Trials as Topic-
dc.subject.meshCongresses as Topic-
dc.subject.meshGene Therapy-
dc.subject.meshGreat Britain-
dc.subject.meshIreland-
dc.subject.meshNeoplasms-
dc.subject.meshSocieties, Medical-
dc.titleTripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Haematological Medicine, King's College London School of Medicine, The Rayne Institute, London SE5 9NU, United Kingdom. barbara.guinn@kcl.ac.uken_GB
dc.identifier.journalHuman gene therapyen_GB
This item is licensed under a Creative Commons License
Creative Commons
All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.